Company · CIK 0000879169 · SIC 8731 — Services-Commercial Physical & Biological Research · Nasdaq
INCYTE CORP · INCY
Insider activity reported against this company. All insider holders · Files at: AGEN, MRUS. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2017 AForm 4 → | Jul 5, 4:21 pm EDT | Paul A BrookeDirector | 188 | $125.91 | $23,671 | 197,121 | — | plan? |
| Jun 30, 2017 AForm 4 → | Jul 5, 4:17 pm EDT | Jean Jacques BienaimeDirector | 115 | $125.91 | $14,480 | 4,792 | — | plan? |
| Jun 30, 2017 SForm 4 → | Jul 5, 4:12 pm EDT | David W GryskaExecutive Vice President, CFO | 599 | $129.74 | $77,714 | 19,015 | −3.05% | plan? |
| Jun 30, 2017 MForm 4 → | Jul 5, 4:12 pm EDT | David W GryskaExecutive Vice President, CFO | 599 | $73.21 | $43,853 | 19,614 | — | plan? |
| Jun 20, 2017 SForm 4 → | Jun 22, 4:29 pm EDT | Steven H SteinEVP & Chief Medical Officer | 9,883 | $125.00 | $1,235,375 | 14,648 | −40.3% | plan? |
| Jun 20, 2017 MForm 4 → | Jun 22, 4:29 pm EDT | Steven H SteinEVP & Chief Medical Officer | 9,883 | $91.45 | $903,824 | 24,531 | — | plan? |
| Jun 12, 2017 SForm 4 → | Jun 14, 4:50 pm EDT | David W GryskaExecutive Vice President, CFO | 16,756 | $116.60 | $1,953,750 | 19,015 | −46.8% | plan? |
| Jun 12, 2017 MForm 4 → | Jun 14, 4:50 pm EDT | David W GryskaExecutive Vice President, CFO | 16,756 | $73.21 | $1,226,707 | 35,771 | — | plan? |
| Jun 6, 2017 MForm 4 → | Jun 7, 4:21 pm EDT | Eric H. SiegelEVP, General Counsel | 1,292 | $66.66 | $86,127 | 18,216 | — | plan? |
| Jun 5, 2017 SForm 4 → | Jun 7, 4:12 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $132.50 | $397,500 | 10,950 | −21.5% | plan? |
| Jun 5, 2017 MForm 4 → | Jun 7, 4:12 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $17.79 | $53,370 | 13,950 | — | plan? |
| Jun 1, 2017 SForm 4 → | Jun 2, 4:22 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $130.00 | $236,600 | 16,924 | −9.71% | plan? |
| Jun 1, 2017 MForm 4 → | Jun 2, 4:22 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $64.55 | $117,481 | 18,744 | — | plan? |
| May 31, 2017 PForm 4 → | Jun 2, 4:14 pm EDT | Jean Jacques BienaimeDirector | 500 | $131.80 | $65,900 | 4,677 | +12.0% | plan? |
| May 15, 2017 PForm 4 → | May 17, 4:18 pm EDT | Jean Jacques BienaimeDirector | 500 | $115.00 | $57,500 | 4,177 | +13.6% | plan? |
| May 8, 2017 SForm 4 → | May 9, 4:38 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 8,577 | $119.21 | $1,022,464 | 36,037 | −19.2% | plan? |
| May 5, 2017 FForm 4 → | May 9, 4:38 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 7,732 | $125.00 | $966,500 | 44,614 | — | plan? |
| May 5, 2017 FForm 4 → | May 9, 4:33 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 4,413 | $125.00 | $551,625 | 33,767 | — | plan? |
| May 5, 2017 SForm 4 → | May 9, 4:17 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $121.70 | $365,100 | 10,950 | −21.5% | plan? |
| May 5, 2017 MForm 4 → | May 9, 4:17 pm EDT | Paul TrowerPrincipal Accounting Officer | 3,000 | $17.79 | $53,370 | 13,950 | — | plan? |
| May 1, 2017 SForm 4 → | May 2, 6:01 pm EDT | Barry P FlannellyEVP & General Manager US | 5,296 | $124.73 | $660,564 | 12,653 | −29.5% | plan? |
| May 1, 2017 MForm 4 → | May 2, 6:01 pm EDT | Barry P FlannellyEVP & General Manager US | 2,064 | $48.44 | $99,980 | 17,949 | — | plan? |
| May 1, 2017 SForm 4 → | May 2, 5:52 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $124.73 | $227,009 | 16,924 | −9.71% | plan? |
| May 1, 2017 MForm 4 → | May 2, 5:52 pm EDT | Eric H. SiegelEVP, General Counsel | 1,820 | $64.55 | $117,481 | 18,744 | — | plan? |
| Apr 28, 2017 SForm 4 → | May 2, 5:39 pm EDT | David W GryskaExecutive Vice President, CFO | 1,389 | $124.26 | $172,597 | 19,015 | −6.81% | plan? |
| Apr 28, 2017 MForm 4 → | May 2, 5:39 pm EDT | David W GryskaExecutive Vice President, CFO | 1,389 | $67.06 | $93,146 | 20,404 | — | plan? |
| Apr 28, 2017 PForm 4 → | May 2, 4:31 pm EDT | Jean Jacques BienaimeDirector | 500 | $124.26 | $62,130 | 3,677 | +15.7% | plan? |
| Apr 27, 2017 MForm 4 → | Apr 28, 5:10 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 60,000 | $7.26 | $435,600 | 787,237 | — | plan? |
| Apr 13, 2017 PForm 4 → | Apr 17, 4:56 pm EDT | Jean Jacques BienaimeDirector | 1,000 | $139.66 | $139,660 | 3,177 | +45.9% | plan? |
| Apr 10, 2017 SForm 4 → | Apr 11, 4:19 pm EDT | Eric H. SiegelEVP, General Counsel | 4,043 | $140.18 | $566,748 | 16,785 | −19.4% | plan? |
| Apr 10, 2017 MForm 4 → | Apr 11, 4:19 pm EDT | Eric H. SiegelEVP, General Counsel | 4,043 | $39.13 | $158,206 | 20,828 | — | plan? |
| Apr 10, 2017 SForm 4 → | Apr 11, 4:14 pm EDT | David W GryskaExecutive Vice President, CFO | 41,528 | $138.00 | $5,730,864 | 19,015 | −68.6% | plan? |
| Apr 10, 2017 MForm 4 → | Apr 11, 4:14 pm EDT | David W GryskaExecutive Vice President, CFO | 41,528 | $67.06 | $2,784,868 | 60,543 | — | plan? |
| Apr 7, 2017 SForm 4 → | Apr 11, 4:24 pm EDT | Steven H SteinEVP & Chief Medical Officer | 32,000 | $137.88 | $4,412,310 | 14,648 | −68.6% | plan? |
| Apr 7, 2017 MForm 4 → | Apr 11, 4:24 pm EDT | Steven H SteinEVP & Chief Medical Officer | 32,000 | $89.79 | $2,873,160 | 46,648 | — | plan? |
| Apr 7, 2017 PForm 4 → | Apr 11, 4:06 pm EDT | Jean Jacques BienaimeDirector | 1,000 | $139.48 | $139,480 | 2,177 | +85.0% | plan? |
| Mar 31, 2017 AForm 4 → | Apr 4, 7:33 pm EDT | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 426 | $133.67 | $56,943 | 767,237 | — | plan? |
| Mar 31, 2017 AForm 4 → | Mar 31, 5:21 pm EDT | Wendy L DixonDirector | 121 | $133.67 | $16,174 | 8,833 | — | plan? |
| Mar 31, 2017 AForm 4 → | Mar 31, 5:10 pm EDT | Paul A BrookeDirector | 177 | $133.67 | $23,660 | 196,933 | — | plan? |
| Mar 31, 2017 AForm 4 → | Mar 31, 5:06 pm EDT | Jean Jacques BienaimeDirector | 108 | $133.67 | $14,436 | 1,177 | — | plan? |
| Mar 17, 2017 SForm 4 → | Mar 20, 4:14 pm EDT | Paul A BrookeDirector | 20,000 | $147.75 | $2,955,000 | 196,756 | −9.23% | plan? |
| Mar 17, 2017 MForm 4 → | Mar 20, 4:14 pm EDT | Paul A BrookeDirector | 20,000 | $7.26 | $145,200 | 216,756 | — | plan? |
| Mar 16, 2017 SForm 4 → | Mar 20, 4:10 pm EDT | Paul A FriedmanDirector | 50,000 | $148.72 | $7,436,164 | 297,518 | −14.4% | plan? |
| Mar 16, 2017 MForm 4 → | Mar 20, 4:10 pm EDT | Paul A FriedmanDirector | 50,000 | $18.32 | $916,000 | 339,211 | — | plan? |
| Feb 27, 2017 SForm 4 → | Mar 1, 4:56 pm EST | Reid M HuberEVP, Chief Scientific Officer | 2,008 | $131.88 | $264,815 | 52,262 | −3.70% | plan? |
| Feb 24, 2017 FForm 4 → | Feb 28, 4:30 pm EST | Paul TrowerPrincipal Accounting Officer | 418 | $121.95 | $50,975 | 10,613 | — | plan? |
| Feb 23, 2017 SForm 4 → | Feb 27, 4:54 pm EST | Paul A FriedmanDirector | 50,000 | $120.32 | $6,016,000 | 297,518 | −14.4% | plan? |
| Feb 23, 2017 MForm 4 → | Feb 27, 4:54 pm EST | Paul A FriedmanDirector | 50,000 | $18.32 | $916,000 | 347,518 | — | plan? |
| Feb 17, 2017 AForm 4 → | Feb 22, 7:49 pm EST | Julian Baker +6Director, 10% Owner | 10,610,782 | — | — | 767,095 | — | plan? |
| Feb 14, 2017 AFForm 4 → | Feb 28, 5:02 pm EST | Herve HoppenotChairman / CEO, Director | 58,349 | $121.95 | $4,990,316 | 358,313 | — | plan? late |
| Feb 14, 2017 AFForm 4 → | Feb 28, 4:51 pm EST | Eric H. SiegelEVP, General Counsel | 4,770 | $121.95 | $156,828 | 16,785 | — | plan? late |
| Feb 14, 2017 AFForm 4 → | Feb 28, 4:48 pm EST | Barry P FlannellyEVP & General Manager US | 9,439 | $121.95 | $301,582 | 15,743 | — | plan? late |
| Feb 14, 2017 AFForm 4 → | Feb 28, 4:43 pm EST | Yao WenqingEVP, Head of Discovery Chem | 3,110 | $121.95 | $96,097 | 37,843 | — | plan? late |
| Feb 14, 2017 AFForm 4 → | Feb 28, 4:39 pm EST | Paula J SwainEVP, Human Resources | 4,666 | $121.95 | $144,145 | 31,550 | — | plan? late |
| Jan 9, 2017 SForm 4 → | Jan 11, 4:21 pm EST | Reid M HuberEVP, Chief Scientific Officer | 11,739 | $113.55 | $1,332,963 | 52,185 | −18.4% | plan? |
| Dec 30, 2016 AForm 4 → | Jan 4, 2017, 6:01 pm EST | Julian Baker +6Director, 10% Owner | 567 | $100.27 | $56,853 | 533,909 | — | plan? |
| Dec 30, 2016 AForm 4 → | Dec 30, 5:13 pm EST | Wendy L DixonDirector | 162 | $100.27 | $16,244 | 8,712 | — | plan? |
| Dec 30, 2016 AForm 4 → | Dec 30, 5:10 pm EST | Paul A BrookeDirector | 236 | $100.27 | $23,664 | 196,756 | — | plan? |
| Dec 30, 2016 AForm 4 → | Dec 30, 5:07 pm EST | Jean Jacques BienaimeDirector | 144 | $100.27 | $14,439 | 1,069 | — | plan? |
| Nov 15, 2016 SForm 4 → | Nov 17, 4:29 pm EST | Paula J SwainEVP, Human Resources | 10,000 | $103.26 | $1,032,600 | 29,248 | −25.5% | plan? |
| Nov 15, 2016 MForm 4 → | Nov 17, 4:29 pm EST | Paula J SwainEVP, Human Resources | 10,000 | $14.72 | $147,200 | 39,248 | — | plan? |
| Nov 9, 2016 SForm 4 → | Nov 10, 4:34 pm EST | Reid M HuberEVP, Chief Scientific Officer | 2,715 | $109.95 | $298,514 | 63,924 | −4.07% | plan? |
| Oct 20, 2016 SForm 4 → | Oct 24, 4:44 pm EDT | Paula J SwainEVP, Human Resources | 10,000 | $90.00 | $900,000 | 29,248 | −25.5% | plan? |
| Oct 20, 2016 MForm 4 → | Oct 24, 4:44 pm EDT | Paula J SwainEVP, Human Resources | 10,000 | $14.72 | $147,200 | 39,248 | — | plan? |
| Oct 7, 2016 SForm 4 → | Oct 11, 4:37 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 11,709 | $96.40 | $1,128,748 | 66,601 | −15.0% | plan? |
| Oct 7, 2016 MForm 4 → | Oct 11, 4:37 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 11,709 | $18.32 | $214,509 | 78,310 | — | plan? |
| Oct 7, 2016 SForm 4 → | Oct 11, 4:33 pm EDT | Barry P FlannellyEVP & General Manager US | 24,204 | $97.00 | $2,347,788 | 11,187 | −68.4% | plan? |
| Oct 7, 2016 MForm 4 → | Oct 11, 4:33 pm EDT | Barry P FlannellyEVP & General Manager US | 24,204 | $48.44 | $1,172,442 | 35,391 | — | plan? |
| Sep 30, 2016 AForm 4 → | Oct 4, 6:33 pm EDT | Julian Baker +6Director, 10% Owner | 603 | $94.29 | $56,857 | 533,720 | — | plan? |
| Sep 30, 2016 AForm 4 → | Oct 4, 4:43 pm EDT | Wendy L DixonDirector | 172 | $94.29 | $16,218 | 8,550 | — | plan? |
| Sep 30, 2016 AForm 4 → | Oct 4, 4:41 pm EDT | Paul A BrookeDirector | 251 | $94.29 | $23,667 | 196,520 | — | plan? |
| Sep 30, 2016 AForm 4 → | Oct 4, 4:39 pm EDT | Jean Jacques BienaimeDirector | 153 | $94.29 | $14,426 | 925 | — | plan? |
| Sep 23, 2016 SForm 4 → | Sep 26, 4:34 pm EDT | Paula J SwainEVP, Human Resources | 20,000 | $90.00 | $1,800,000 | 29,248 | −40.6% | plan? |
| Sep 23, 2016 MForm 4 → | Sep 26, 4:34 pm EDT | Paula J SwainEVP, Human Resources | 20,000 | $14.72 | $294,400 | 49,248 | — | plan? |
| Aug 2, 2016 SForm 4 → | Aug 2, 5:09 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 10,000 | $87.96 | $879,600 | 66,601 | −13.1% | plan? |
| Jul 29, 2016 SForm 4 → | Aug 2, 4:54 pm EDT | Paula J SwainEVP, Human Resources | 60,000 | $90.00 | $5,400,000 | 29,248 | −67.2% | plan? |
| Jul 29, 2016 MForm 4 → | Aug 2, 4:54 pm EDT | Paula J SwainEVP, Human Resources | 60,000 | $14.72 | $883,200 | 89,248 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:46 pm EDT | Yao WenqingEVP, Head of Discovery Chem | 5,555 | — | — | 36,102 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:45 pm EDT | Paul TrowerPrincipal Accounting Officer | 2,406 | — | — | 10,824 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:45 pm EDT | Paula J SwainEVP, Human Resources | 5,555 | — | — | 29,248 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:44 pm EDT | Steven H SteinEVP & Chief Medical Officer | 5,555 | — | — | 14,648 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:43 pm EDT | Eric H. SiegelEVP, General Counsel | 5,555 | — | — | 14,384 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:43 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 5,555 | — | — | 76,601 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:42 pm EDT | Herve HoppenotChairman / CEO, Director | 21,603 | — | — | 381,806 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:41 pm EDT | David W GryskaExecutive Vice President, CFO | 5,555 | — | — | 19,015 | — | plan? |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:40 pm EDT | Barry P FlannellyEVP & General Manager US | 5,555 | — | — | 11,187 | — | plan? |
| Jun 30, 2016 AForm 4 → | Jul 5, 5:13 pm EDT | Julian Baker +6Director, 10% Owner | 711 | $79.98 | $56,866 | 533,519 | — | plan? |
| Jun 30, 2016 AForm 4 → | Jul 5, 4:32 pm EDT | Wendy L DixonDirector | 203 | $79.98 | $16,236 | 8,378 | — | plan? |
| Jun 30, 2016 AForm 4 → | Jul 5, 4:31 pm EDT | Paul A BrookeDirector | 296 | $79.98 | $23,674 | 196,269 | — | plan? |
| Jun 30, 2016 AForm 4 → | Jul 5, 4:31 pm EDT | Jean Jacques BienaimeDirector | 181 | $79.98 | $14,476 | 772 | — | plan? |
| May 9, 2016 AForm 4 → | May 11, 5:15 pm EDT | Vijay K IyengarEVP GPS, BD, & Licensing | 4,632 | — | — | 4,632 | — | plan? |
| Apr 1, 2016 MForm 4 → | Apr 5, 4:30 pm EDT | Paul A BrookeDirector | 20,000 | $3.86 | $77,200 | 195,973 | — | plan? |
| Mar 31, 2016 AForm 4 → | Apr 4, 6:32 pm EDT | Julian Baker +6Director, 10% Owner | 786 | $72.47 | $56,961 | 533,282 | — | plan? |
| Mar 31, 2016 AForm 4 → | Apr 1, 4:11 pm EDT | Wendy L DixonDirector | 224 | $72.47 | $16,233 | 8,175 | — | plan? |
| Mar 31, 2016 AForm 4 → | Apr 1, 4:11 pm EDT | Paul A BrookeDirector | 327 | $72.47 | $23,698 | 175,973 | — | plan? |
| Mar 31, 2016 AForm 4 → | Apr 1, 4:10 pm EDT | Jean Jacques BienaimeDirector | 200 | $72.47 | $14,494 | 591 | — | plan? |
| Mar 17, 2016 MForm 4 → | Mar 17, 7:14 pm EDT | Julian Baker +6Director, 10% Owner | 60,000 | $3.86 | $231,600 | 533,020 | — | plan? |
| Mar 15, 2016 PForm 4 → | Mar 17, 7:14 pm EDT | Julian Baker +6Director, 10% Owner | 800,000 | $63.98 | $51,184,194 | 19,757,285 | +4.22% | plan? |
| Feb 25, 2016 MForm 4 → | Feb 29, 4:28 pm EST | Yao WenqingEVP, Discovery Medicinal and P | 6,566 | $18.32 | $120,289 | 30,547 | — | plan? |
| Feb 24, 2016 PForm 4 → | Feb 26, 4:42 pm EST | Julian Baker +6Director, 10% Owner | 64,290 | $70.79 | $4,550,987 | 19,015,852 | +0.34% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2015 MForm 4 → | Apr 24, 4:20 pm EDT | James M DalyEVP, Chief Commercial Officer | 36,941 | — | — | 19,624 | — | |
| Apr 16, 2015 MForm 4 → | Apr 17, 5:10 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 10,060 | — | — | 0 | — | |
| Apr 14, 2015 MForm 4 → | Apr 16, 4:29 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 6,735 | — | |
| Apr 13, 2015 MForm 4 → | Apr 14, 4:15 pm EDT | Paula J SwainEVP, Human Resources | 16,469 | — | — | 0 | — | |
| Apr 10, 2015 MForm 4 → | Apr 14, 4:14 pm EDT | Yao WenqingEVP, Discovery Medicinal and P | 23,000 | — | — | 35,354 | — | |
| Apr 7, 2015 MForm 4 → | Apr 8, 4:18 pm EDT | Yao WenqingEVP, Discovery Medicinal and P | 5,000 | — | — | 58,354 | — | |
| Apr 6, 2015 MForm 4 → | Apr 8, 4:17 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 25,000 | — | — | 41,782 | — | |
| Mar 30, 2015 MForm 4 → | Apr 1, 4:27 pm EDT | Laurent ChardonnetOther | 113,776 | — | — | 0 | — | |
| Mar 30, 2015 MForm 4 → | Apr 1, 4:26 pm EDT | Reid M HuberEVP, Chief Scientific Officer | 34,263 | — | — | 0 | — | |
| Mar 16, 2015 MForm 4 → | Mar 18, 4:33 pm EDT | Paula J SwainEVP, Human Resources | 17,500 | — | — | 16,469 | — | |
| Mar 12, 2015 MForm 4 → | Mar 13, 4:28 pm EDT | Barry A ArikoDirector | 80,000 | — | — | 0 | — | |
| Mar 12, 2015 MForm 4 → | Mar 13, 4:27 pm EDT | Eric H. SiegelEVP, General Counsel | 2,222 | — | — | 7,021 | — | |
| Mar 10, 2015 MForm 4 → | Mar 10, 5:36 pm EDT | Yao WenqingEVP, Discovery Medicinal and P | 4,404 | — | — | 0 | — | |
| Mar 6, 2015 MForm 4 → | Mar 10, 5:13 pm EDT | Richard S LevyEVP, Chief Drug Dev Officer | 25,000 | — | — | 66,782 | — | |
| Mar 5, 2015 MForm 4 → | Mar 9, 4:37 pm EDT | Eric H. SiegelEVP, General Counsel | 13,333 | — | — | 7,307 | — | |
| Mar 5, 2015 MForm 4 → | Mar 9, 4:35 pm EDT | Richard U De SchutterDirector | 40,000 | — | — | 0 | — | |
| Feb 25, 2015 MForm 4 → | Feb 25, 5:29 pm EST | Eric H. SiegelEVP, General Counsel | 13,333 | — | — | 7,593 | — | |
| Feb 23, 2015 MForm 4 → | Feb 25, 5:29 pm EST | James M DalyEVP, Chief Commercial Officer | 11,112 | — | — | 4,813 | — | |
| Feb 18, 2015 MForm 4 → | Feb 20, 4:43 pm EST | Barry A ArikoDirector | 20,000 | — | — | 0 | — | |
| Feb 17, 2015 MForm 4 → | Feb 18, 5:49 pm EST | Richard S LevyEVP, Chief Drug Dev&Medical Of | 12,000 | — | — | 0 | — | |
| Feb 17, 2015 MForm 4 → | Feb 18, 5:47 pm EST | Paula J SwainEVP, Human Resources | 17,500 | — | — | 33,969 | — | |
| Feb 6, 2015 MForm 4 → | Feb 10, 4:33 pm EST | Richard S LevyEVP, Chief Drug Dev&Medical Of | 25,000 | — | — | 91,782 | — | |
| Jan 23, 2015 MForm 4 → | Jan 26, 4:57 pm EST | James M DalyEVP, Chief Commercial Officer | 11,109 | — | — | 30,655 | — | |
| Jan 22, 2015 MForm 4 → | Jan 26, 4:57 pm EST | Eric H. SiegelEVP, General Counsel | 13,542 | — | — | 0 | — | |
| Jan 20, 2015 AForm 4 → | Jan 22, 4:04 pm EST | Paul J ClancyDirector | 30,000 | — | — | 5,000 | — | |
| Jan 20, 2015 AForm 4 → | Jan 22, 4:04 pm EST | Jean Jacques BienaimeDirector | 30,000 | — | — | 5,000 | — | |
| Jan 20, 2015 MForm 4 → | Jan 20, 5:28 pm EST | Paula J SwainEVP, Human Resources | 17,500 | — | — | 51,469 | — | |
| Jan 16, 2015 MForm 4 → | Jan 20, 5:27 pm EST | Richard S LevyEVP, Chief Drug Dev&Medical Of | 12,000 | — | — | 8,317 | — | |
| Jan 8, 2015 MForm 4 → | Jan 12, 5:06 pm EST | Eric H. SiegelEVP, General Counsel | 15,626 | — | — | 0 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:03 pm EST | Yao WenqingEVP, Discovery Medicinal and P | 41,545 | — | — | 1,365 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:02 pm EST | Paula J SwainEVP, Human Resources | 21,545 | — | — | 1,356 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:02 pm EST | Eric H. SiegelEVP, General Counsel | 21,545 | — | — | 1,356 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:01 pm EST | Richard S LevyEVP, Chief Drug Dev&Medical Of | 21,545 | — | — | 1,085 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:01 pm EST | Reid M HuberEVP, Chief Scientific Officer | 51,545 | — | — | 1,365 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:01 pm EST | Herve HoppenotChief Executive Officer, Director | 89,771 | — | — | 1,365 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:00 pm EST | David W GryskaExecutive Vice President, CFO | 21,545 | — | — | 599 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:00 pm EST | Barry P FlannellyEVP, Business Development | 21,545 | — | — | 599 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 7:00 pm EST | James M DalyEVP, Chief Commercial Officer | 21,545 | — | — | 1,099 | — | |
| Jan 8, 2015 AForm 4 → | Jan 9, 6:59 pm EST | Laurent ChardonnetOther | 13,984 | — | — | 1,365 | — | |
| Jan 6, 2015 MForm 4 → | Jan 8, 5:34 pm EST | Richard S LevyEVP, Chief Drug Dev&Medical Of | 25,000 | — | — | 116,782 | — | |
| Jan 5, 2015 MForm 4 → | Jan 7, 4:29 pm EST | Paula J SwainEVP, Human Resources | 17,500 | — | — | 68,969 | — |
Filed by this entity as an insider elsewhere — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2017 PForm 4 → | Feb 14, 5:26 pm EST | AGENUS INCAGEN | 10,000,000 | $6.00 | $60,000,000 | 17,763,968 | +129% | plan? |
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.